Inferra AI / Company / SEPN
Septerna, Inc.
SEPN · Health Care
Last earnings Aug 10, 2026
Key results
Revenuequarter
$26.5 million
o Revenue: Revenue from the Novo Nordisk collaboration was $26.5 million for the quarter ended March 31, 2026, compared to $0.2 million from Vertex for the quarter ended March 31, 2025.
SEC original ↗Septerna, Inc. — Earnings release (8-K exhibit)EX-99May 11, 2026
AI analysis
Q1 2026 · reported May 11, 2026
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance · company-stated
No guidance located in the held release
Capital allocation
government agency securities, commercial paper, and corporate debt securities, are classified as Level 2.
government agency securities 4,224 4,224 Total measured at fair value $ 544,025 $ 63,736 $ 480,289 $ Marketable Securities As of June 30, 2026 and December 31, 2025, the Company s marketable securities consist of debt securities, including U.
Event summary
“In the first quarter, we continued to make meaningful progress across our pipeline, highlighted by positive Phase 1 clinical results for SEP-631 and the initiation of our Phase 1 clinical trial for SEP-479,” said Jeffrey
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
No guidance located in the held release
Capital allocation
government agency securities, commercial paper, and corporate debt securities, are classified as Level 2.
SEC original ↗Septerna, Inc. — 10-Q Quarterly report10-QAug 10, 2026
government agency securities 4,224 4,224 Total measured at fair value $ 544,025 $ 63,736 $ 480,289 $ Marketable Securities As of June 30, 2026 and December 31, 2025, the Company s marketable securities consist of debt securities, including U.
SEC original ↗Septerna, Inc. — 10-Q Quarterly report10-QAug 10, 2026
Strategy & priorities
The collaboration included the Company's most advanced preclinical metabolic program focused on developing an oral small molecule agonist to the GIP receptor.
SEC original ↗Septerna, Inc. — 10-Q Quarterly report10-QAug 10, 2026
Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.
SEC original ↗Septerna, Inc. — 10-Q Quarterly report10-QAug 10, 2026
Risks & headwinds
These and other risks and uncertainties are described in greater detail in the section entitled “Risk Factors” in Septerna’s Annual Report on Form 10-K for the year ended December 31, 2025, as well as any subsequent filings with the Securities and Exchange Commission.
SEC original ↗Septerna, Inc. — Earnings release (8-K exhibit)EX-99May 11, 2026
Legal Proceedings 34 Item 1A.
SEC original ↗Septerna, Inc. — 10-Q Quarterly report10-QAug 10, 2026
Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements.
SEC original ↗Septerna, Inc. — 10-Q Quarterly report10-QAug 10, 2026
federal government shutdown or reduced resources, new or increased international tariffs and retaliatory tariffs, trade protection measures, economic sanctions and economic slowdowns or recessions that may result from such developments which could harm our research and development efforts as well as the value of our common stock and our ability to access capital markets; and other risks and uncertainties, including those listed under the section titled Risk Factors in Part II, Item 1A in this Quarterly Report.
SEC original ↗Septerna, Inc. — 10-Q Quarterly report10-QAug 10, 2026
You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond our control and which could materially affect results.
SEC original ↗Septerna, Inc. — 10-Q Quarterly report10-QAug 10, 2026
If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements.
SEC original ↗Septerna, Inc. — 10-Q Quarterly report10-QAug 10, 2026
Earnings deck slides
0 decks with slide viewSepterna, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Septerna, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Septerna, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Septerna, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Septerna, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
36 documents- Q2 2026
- 8-KSEPN
Aug 25, 2026
- 8-KSEPN
Aug 10, 2026
- 10-QSEPN
Aug 10, 2026
- Q1 2026
- 8-KSEPN
Jun 30, 2026
- 8-KSEPN
May 11, 2026
- 10-QSEPN
May 11, 2026
- 8-KSEPN
Apr 13, 2026
- Q4 2025
- 8-KSEPN
Mar 9, 2026
- 10-KSEPN
Mar 9, 2026
- 8-KSEPN
Mar 2, 2026
- EX-99SEPN
Mar 2, 2026
- 8-KSEPN
Jan 12, 2026
- 8-KSEPN
Jan 8, 2026
- EX-99SEPN
Jan 8, 2026
- Q3 2025
- 8-KSEPN
Nov 10, 2025
- 10-QSEPN
Nov 10, 2025
- Q2 2025
- 8-KSEPN
Sep 29, 2025
- EX-99SEPN
Sep 29, 2025
- 8-KSEPN
Sep 3, 2025
- 8-KSEPN
Aug 21, 2025
- EX-99SEPN
Aug 21, 2025
- 8-KSEPN
Aug 11, 2025
- 10-QSEPN
Aug 11, 2025
- 8-KSEPN
Aug 4, 2025
- 8-KSEPN
Jul 2, 2025
- Q1 2025
- 8-KSEPN
Jun 18, 2025
- 8-KSEPN
May 15, 2025
- 10-QSEPN
May 15, 2025
- 8-KSEPN
May 14, 2025
- EX-99SEPN
May 14, 2025
- Q4 2024
- 10-KSEPN
Mar 27, 2025
- 8-KSEPN
Mar 27, 2025
- 8-KSEPN
Mar 3, 2025
- 8-KSEPN
Feb 18, 2025
- EX-99SEPN
Feb 18, 2025
- 8-KSEPN
Jan 13, 2025
Earnings releases
10 documentsPresentations
5 documentsTranscripts
0 documentsNo transcripts for Septerna, Inc. are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.